Cloud Banner

Healthcare

Image

Global Array Instruments Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Array Instruments Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 5.800000000000001% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 1.10 Billion
Diagram Market Size (Forecast Year) USD 1.73 Billion
Diagram CAGR 5.800000000000001%

Global Array Instruments Market, By Technology (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays), End User (Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Veterinary Laboratories, Forensic Centers) – Industry Trends and Forecast to 2029.

Array Instruments Market Analysis and Size

The market for array instruments is expected to grow in the forecast region of 2022-2029. The increased demand for the diagnosis and prognosis of many chronic diseases, particularly cancer, is the main factor driving the market. The increasing prevalence of various ailments around the world and the growing need to identify their origin and subsequently determine a course of therapy for them are fuelling market expansion.

Data Bridge Market Research analyses that the array instruments market which was USD 1.1 billion in 2021, would rocket up to USD 1.73 billion by 2029, and is expected to undergo a CAGR of 5.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Array Instruments Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays), End User (Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Veterinary Laboratories, Forensic Centers),

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Arrayit Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), OriGene Technologies, Inc. (U.S.), Oxford Gene Technology IP Limited (U.K.), Pepscan (U.S.), PerkinElmer Inc. (U.S.), Phalanx Biotech Group (China), QIAGEN (Germany), RayBiotech Life Inc. (U.S.), Retrogenix (U.K.), Luminex Corporation (U.S.), MESO SCALE DIAGNOSTICS, LLC (U.S.)

Market Opportunities

  • Increasing awareness amongst the physicians and patients

Market Definition

Array instruments are the equipment that help in concurrently and quantitatively monitoring the amounts of gene expression in a single reaction. Numerous areas of the genome are also genotyped using them. They entail the assembly on a single histologic slide of numerous tiny representative tissue samples from distinct instances. They aid in identifying chromosomal expressions and genotype mutations and measuring and identifying messenger RNA (mRNA) level gene expressions.

Global Array Instruments Market Dynamics

Drivers

  • Rising number of patients with diseases

The rising number of patients with cancer and other diseases, the increasing demand for array instruments for disease early detection, the adoption of cutting-edge and ground-breaking technology like DNA microarrays, and the rising number of applications from developing economies are all expected to contribute to the market's rapid growth over the forecast period of 2022–2029.

  • Growing demand for customised medications

Growing demand for customised medications and focused therapies, combined with the availability of precise tools, will further stimulate the opportunities that will fuel the expansion of the market for a variety of instruments during the period covered by the forecast.

Opportunities

  • Rising demand for their early identification and diagnosis

The main reasons propelling the expansion of the global market for array instruments is the rising prevalence of chronic diseases and the rising demand for their early identification and diagnosis. Additionally, governments in various nations are spending money to upgrade healthcare facilities, which is favourably impacting the market for array instruments, particularly in developing economies.

Restraints/Challenges

The lack of data analysis tools in developing nations will restrain the market's expansion for various instruments during the forecast period. The major obstacle to the market's expansion will be the escalating rivalry and emerging technology.

This array instruments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the array instruments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Array Instruments Market

The stock market reached its top position prior to the pandemic and the appearance of the new strain omicron. The creation of masks and hand sanitizers has become more popular among brands in recent years. On the other hand, it is anticipated that things will return to normal as the number of immunizations rises. The array instruments market has developed after the lockdown and other limitations were lifted.

Global Array Instruments Market Scope

The array instruments market is segmented on the basis of technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Technology

  • DNA Microarrays
  • Protein Microarrays
  • Cellular Microarrays
  • Tissue Microarrays

 End User

  • Research and Development Laboratories
  • Clinical Diagnostic Labs
  • Agriculture Research Centers
  • Veterinary Laboratories
  • Forensic Centers

Array Instruments Market Regional Analysis/Insights

The array instruments market is analysed and market size insights and trends are provided by country, technology and end-user as referenced above.

The countries covered in the array instruments market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the array instruments market due to the increasing adoption of advanced technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Array Instruments Market Share Analysis

The array instruments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to array instruments market.

Some of the major players operating in the array instruments market are:

  • Thermo Fisher Scientific Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Illumina, Inc. (U.S.)
  • Arrayit Corporation (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)
  • OriGene Technologies, Inc. (U.S.)
  • Oxford Gene Technology IP Limited (U.K.)
  • Pepscan (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Phalanx Biotech Group (China)
  • QIAGEN (Germany)
  • RayBiotech Life Inc. (U.S.)
  • Retrogenix (U.K.)
  • Luminex Corporation (U.S.)
  • MESO SCALE DIAGNOSTICS, LLC (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The array instruments market value is generating 1.73 billion USD forecasted till 2029.
The array instruments market is projected to grow at a CAGR of 5.80% during the forecast period of 2022-2029.
On the basis of technology, the Array Instruments Market is segmented into DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays.
The major players operating in the Array Instruments Market are Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Arrayit Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), OriGene Technologies, Inc. (U.S.), Oxford Gene Technology IP Limited (U.K.), Pepscan (U.S.), PerkinElmer Inc. (U.S.), Phalanx Biotech Group (China), QIAGEN (Germany), RayBiotech Life Inc. (U.S.), Retrogenix (U.K.), Luminex Corporation (U.S.), MESO SCALE DIAGNOSTICS, LLC (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials